Pharmacological approaches to the treatment of complicated grief: rationale and a brief review of the literature
Authors:
Open Access
- 30 June 2012
- journal article
- review article
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 14 (2) , 149-157
Abstract
Complicated grief (CG) is a common and often under-acknowledged cause of profound impairment experienced after the loss of a loved one. Although both clinical and basic research suggests that pharmacological agents might be of use in the treatment of CG, research on pharmacological approaches to thi …Keywords
This publication has 43 references indexed in Scilit:
- Diurnal cortisol in Complicated and Non-Complicated Grief: Slope differences across the dayPsychoneuroendocrinology, 2012
- Complicated grief and related bereavement issues for DSM-5Depression and Anxiety, 2011
- Escitalopram: An open-label study of bereavement-related depression and griefJournal of Affective Disorders, 2009
- Posttraumatic stress disorder in general intensive care unit survivors: a systematic reviewGeneral Hospital Psychiatry, 2008
- Craving love? Enduring grief activates brain's reward centerNeuroImage, 2008
- Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated griefPsychiatry Research, 2008
- A Double-Blind, Placebo-Controlled Pilot Trial of Quetiapine for the Treatment of Type A and Type B AlcoholismJournal of Clinical Psychopharmacology, 2007
- Prevalence and psychological correlates of complicated grief among bereaved adults 2.5–3.5 years after September 11th attacksJournal of Traumatic Stress, 2007
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant ActionArchives of General Psychiatry, 2006
- A longitudinal study of bereavement phenomena in recently widowed elderly menPsychological Medicine, 1994